Tau in brain aging and AD is progressively altered by post-translational modifications, principally hyper-phosphorylation at many phosphorylation sites, acetylation, abnormal conformation, truncation at the C-terminal and N-terminal regions, oligomerization, fibrillization, and aggregation. This evidence concerns the gene MAPT and Alzheimer disease.